Hemagen Diagnostics (Hemagen Diagnostics) Interest Expense : $-0.47 Mil (TTM As of Sep. 2012)

View and export this data going back to . Start your Free Trial

What is Hemagen Diagnostics Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Hemagen Diagnostics's interest expense for the three months ended in Sep. 2012 was $ -0.12 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2012 was $-0.47 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Hemagen Diagnostics's Operating Income for the three months ended in Sep. 2012 was $ -0.04 Mil. Hemagen Diagnostics's Interest Expense for the three months ended in Sep. 2012 was $ -0.12 Mil. Hemagen Diagnostics did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Hemagen Diagnostics Interest Expense Historical Data

The historical data trend for Hemagen Diagnostics's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hemagen Diagnostics Interest Expense Chart

Hemagen Diagnostics Annual Data

Trend

Sep03

Sep04

Sep05

Sep06

Sep07

Sep08

Sep09

Sep10

Sep11

Sep12

Interest Expense

Get a 7-Day Free Trial

-0.38

-0.40

-0.33

-0.41

-0.47

Hemagen Diagnostics Quarterly Data
	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12
Interest Expense	Get a 7-Day Free Trial															-0.11	-0.11	-0.12	-0.12	-0.12

Hemagen Diagnostics Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2012 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.47 Mil.

Hemagen Diagnostics (OTCPK:HMGN) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Hemagen Diagnostics's Interest Expense for the three months ended in Sep. 2012 was $-0.12 Mil. Its Operating Income for the three months ended in Sep. 2012 was $-0.04 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Sep. 2012 was $4.05 Mil.

Hemagen Diagnostics's Interest Coverage for the quarter that ended in Sep. 2012 is calculated as

Hemagen Diagnostics did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Hemagen Diagnostics (Hemagen Diagnostics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hemagen Diagnostics Inc (OTCPK:HMGN) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

9033 Red Branch Road, Columbia, MD, USA, 21045

Website

http://www.hemagen.com

Hemagen Diagnostics Inc is a biotechnology company. It develops, manufactures and markets Food and Drug Administration cleared proprietary medical diagnostic test kits and components. The company's Virgo line of Immunoassays are used to aid in the diagnosis of autoimmune and infectious diseases and acute-phase proteins. The assays utilize multiple technologies including ELISA, immunofluorescence (IFA) and hemagglutination (HA). Its products include ANA Screen ELISA 96 Test System, Rubella IgG ELISA 96 Test System, AMA IFA 48 Test System and others.

Executives

Howard F Curd

director

Hemagen Diagnostics (Hemagen Diagnostics) Headlines

No Headlines